Science Explorer Back to mapMap
Discussion
Researcher · St. Joseph Hospital · United States

John S. Stehlin

John S. Stehlin publishes mostly in Oncology, Molecular Biology and Radiology, Nuclear Medicine and Imaging, on topics such as Cancer therapeutics and mechanisms, Cutaneous Melanoma Detection and Management and CAR-T cell therapy research.

OpenAlex
World rank
#527,226
of 7,710,434 ranked researchers
Rank in United States
#182,892
of 1,627,098
Works
109
Citations
5.4k
Citations per work
49.3
h-index
35
i10-index 67Top 8.3% in Oncology
John S. Stehlin

What does John S. Stehlin research?

John S. Stehlin's work is mostly in Medicine (38%), Biochemistry, Genetics and Molecular Biology (17%), Immunology and Microbiology (4%).

Health Sciences: 42 works · 38.4% of their workMedicine: 42 works · 38.4% of their workOncology: 30 works · 27.2% of their workRadiology, Nuclear Medicine and Imaging: 8 works · 7.6% of their workPulmonary and Respiratory Medicine: 4 works · 3.6% of their workEverything else: 39 works · 35.6% of their workLife Sciences: 24 works · 21.7% of their workBiochemistry, Genetics and Molecular Biology: 19 works · 17.4% of their workMolecular Biology: 19 works · 17.4% of their workImmunology and Microbiology: 5 works · 4.3% of their workImmunology: 5 works · 4.3% of their workPhysical Sciences: 5 works · 4.3% of their workEngineering: 5 works · 4.3% of their workBiomedical Engineering: 5 works · 4.3% of their workTHEIR WORKJohn S. Stehlin109works
Life Sciences22%Physical Sciences4%Health Sciences38%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine4238.4%
  2. Everything else3935.6%
    1. Biochemistry, Genetics and Molecular Biology1917.4%
    2. Immunology and Microbiology54.3%
    1. Engineering54.3%
  1. 1Oncology27% of their works
  2. 2Molecular Biology17% of their works
  3. 3Radiology, Nuclear Medicine and Imaging8% of their works
  4. 4Immunology4% of their works
  5. 5Biomedical Engineering4% of their works
  6. 6Pulmonary and Respiratory Medicine4% of their works

Research topics

Which keywords describe John S. Stehlin's research?

The keywords of their largest research topics: Immunotherapy, Chemotherapy, Melanoma, DNA, Topoisomerases, Dermoscopy, Skin Cancer and Cancer Immunotherapy.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most.

All 21 words, with their numbers
  1. Immunotherapy353 topics
  2. Chemotherapy302 topics
  3. Melanoma242 topics
  4. DNA231 topic
  5. Topoisomerases231 topic
  6. Dermoscopy181 topic
  7. Skin Cancer181 topic
  8. Cancer Immunotherapy162 topics
  9. Targeted Therapy162 topics
  10. CAR T Cells101 topic
  11. Chimeric Antigen Receptor101 topic
  12. PET Imaging91 topic
  13. Radiopharmaceuticals91 topic
  14. Cancer Stem Cells71 topic
  15. Genomic Profiles71 topic
  16. Small-Cell Lung Cancer71 topic
  17. Tumor Metastasis71 topic
  18. BRAF gene61 topic
  19. Dendritic Cells61 topic
  20. Immunity61 topic
  21. MAP Kinase61 topic

Where does John S. Stehlin work?

John S. Stehlin's main affiliation in the publication record is St. Joseph Hospital, United States.

How many publications and citations does John S. Stehlin have?

OpenAlex counts 109 works and 5,375 citations for John S. Stehlin, an h-index of 35, ranking #527,226 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about John S. Stehlin. Posts are plain text and can be reported.